Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Bullish on Clene NASDAQ CLNN with Strong Buy Rating and 147303 Upside Potential

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Finance_Fiscal (1)
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Clene (NASDAQ: CLNN) has caught the eye of analysts, who unanimously rate it as a Strong Buy following recent evaluations. Projections show a potential upside of 1473.03%, with an average 12-month price target of $7.00. Notably, Joseph Pantginis of HC Wainwright & Co. maintains a Buy rating for Clene with a matching price target. The company is set to release its earnings report on May 6, 2024, after surpassing expectations in the previous quarter with an earnings per share of -$0.02. Analysts are optimistic about Clene’s future performance, citing their assessments and price targets as indicators of a promising outlook.

CLNN Stock Price Drops 0.99% to $0.44 on March 13, 2024: Analysis and Market Outlook

On March 13, 2024, CLNN stock experienced a slight decrease in its price, closing at $0.44. This represents a 0.99% drop from the previous market close. Despite this decrease, the stock is still trading in the middle of its 52-week range and below its 200-day simple moving average.

The after-hours trading also saw a further drop of $0.00 in the price of CLNN shares. While this may not seem significant in terms of dollar value, any decrease in stock price can have an impact on investors and market sentiment.

CLNN Stock Performance Analysis: Mixed Results in Financial Data for March 13, 2024

On March 13, 2024, CLNN stock experienced a mixed performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $473.00K, which represents a 34.58% decrease compared to the previous year. In the most recent quarter, total revenue was $108.00K, showing a significant decline of 59.85% since the last quarter.

Similarly, CLNN’s net income also saw a decline in the past year, with a reported figure of -$29.92M. This represents a substantial decrease of 207.17% compared to the previous year. However, in the most recent quarter, net income improved slightly to -$2.42M, showing an increase of 90.38% since the last quarter.

Earnings per share (EPS) for CLNN stock also followed a similar trend. The EPS for the past year was reported at -$0.46, marking a decrease of 190.01% compared to the previous year. In the most recent quarter, EPS improved to -$0.02, showing an increase of 93.57% since the last quarter.

Overall, the financial performance of CLNN stock on March 13, 2024, indicates a mixed picture. While there were improvements in net income and EPS since the last quarter, the company experienced significant declines in total revenue and net income compared to the previous year. Investors should closely monitor the company’s financial performance and market trends to make informed decisions about their investments in CLNN stock.

Tags: CLNN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Retailers Market Capitalization

Positive Shift in Market Sentiment Towards Starbucks NYSE SBUX

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Anticipating Benson Hills Earnings Announcement A Look at Past Performance and Stock Status

Anticipating Blink Charging Cos Q4 Financial Results Analyst Projections and Company Updates

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com